佐剂
鼻腔给药
化脓性链球菌
肽
抗原
免疫
微生物学
聚乙烯亚胺
免疫系统
病毒学
脂肽
脂质体
链球菌
医学
抗体
生物
免疫学
化学
金黄色葡萄球菌
细菌
生物化学
基因
遗传学
转染
作者
Charles C. Dai,Jieru Yang,Waleed M. Hussein,Lili Zhao,Xiumin Wang,Zeinab G. Khalil,Robert J. Capon,István Tóth,Rachel J. Stephenson
标识
DOI:10.1021/acsinfecdis.0c00452
摘要
Group A Streptococcus (GAS) and GAS-related infections are a worldwide challenge, with no commercial GAS vaccine available. Polyethylenimine (PEI) attaches to the cells’ surface and delivers cargo into endosomal and cytosolic compartments. We hypothesized that this will confer mucosal adjuvant properties for peptide antigens against group A Streptococcus (GAS). In this study, we successfully demonstrated the development of PEI incorporated liposomes for the delivery of a lipopeptide-based vaccine (LCP-1) against GAS. Outbred mice were administrated with the vaccine formulations intranasally, and immunological investigation showed that the PEI liposomes elicited significant mucosal and systemic immunity with the production of IgA and IgG antibodies. Antibodies were shown to effectively opsonize multiple isolates of clinically isolated GAS. This proof-of-concept study showed the capability for PEI liposomes to act as a safe vehicle for the delivery of GAS peptide antigens to elicit immune responses against GAS infection, making PEI a promising addition to liposomal mucosal vaccines.
科研通智能强力驱动
Strongly Powered by AbleSci AI